M. Babjuk

814 total citations
28 papers, 478 citations indexed

About

M. Babjuk is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. Babjuk has authored 28 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in M. Babjuk's work include Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (11 papers) and Urological Disorders and Treatments (4 papers). M. Babjuk is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (11 papers) and Urological Disorders and Treatments (4 papers). M. Babjuk collaborates with scholars based in Czechia, Spain and Finland. M. Babjuk's co-authors include Richard Sylvester, Morgan Rouprêt, Eevi Kaasinen, Richard Zigeuner, Juan Palou, Viktor Soukup, W. Oosterlinck, Andreas Boehle, Michael Pešl and Joan Palou and has published in prestigious journals such as Urology, European Urology Focus and Urologia Internationalis.

In The Last Decade

M. Babjuk

21 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Babjuk Czechia 14 352 106 102 94 90 28 478
Hugh Mostafid United Kingdom 8 274 0.8× 85 0.8× 63 0.6× 79 0.8× 69 0.8× 26 345
Chih‐Hsiung Kang Taiwan 9 286 0.8× 60 0.6× 113 1.1× 47 0.5× 81 0.9× 17 377
Naotaka Nishiyama Japan 12 257 0.7× 49 0.5× 103 1.0× 146 1.6× 116 1.3× 57 444
William Martin‐Doyle United States 8 633 1.8× 212 2.0× 127 1.2× 64 0.7× 160 1.8× 19 729
Catalona Wj United States 8 330 0.9× 98 0.9× 111 1.1× 87 0.9× 91 1.0× 23 466
S. Holmäng Sweden 7 446 1.3× 121 1.1× 79 0.8× 41 0.4× 100 1.1× 17 500
G. Zampa Italy 9 223 0.6× 104 1.0× 39 0.4× 49 0.5× 110 1.2× 41 361
Roberto Contieri Italy 11 231 0.7× 100 0.9× 117 1.1× 87 0.9× 43 0.5× 63 361
Gary Bokinsky United States 6 429 1.2× 113 1.1× 64 0.6× 94 1.0× 44 0.5× 11 488
Soloway Ms United States 11 212 0.6× 80 0.8× 110 1.1× 57 0.6× 59 0.7× 24 331

Countries citing papers authored by M. Babjuk

Since Specialization
Citations

This map shows the geographic impact of M. Babjuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Babjuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Babjuk more than expected).

Fields of papers citing papers by M. Babjuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Babjuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Babjuk. The network helps show where M. Babjuk may publish in the future.

Co-authorship network of co-authors of M. Babjuk

This figure shows the co-authorship network connecting the top 25 collaborators of M. Babjuk. A scholar is included among the top collaborators of M. Babjuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Babjuk. M. Babjuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jarolím, L., et al.. (2022). Risk of biochemical recurrence in patients with a positive surgical margin after radicalprostatectomy. Perspectives in Surgery. 101(3). 129–133.
4.
Dušek, Ladislav, Jan Mužı́k, Tomáš Pavlík, et al.. (2014). Cancer Incidence and Mortality in the Czech Republic. Klinicka onkologie. 27(6). 406–423. 38 indexed citations
5.
Soukup, Viktor, J Dušková, Michael Pešl, et al.. (2014). The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study. Urologia Internationalis. 92(2). 150–156. 24 indexed citations
6.
Rink, Michael, Luis Kluth, Yair Lotan, et al.. (2013). 276 Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. European Urology Supplements. 12(1). e276–e277. 19 indexed citations
7.
Babjuk, M., W. Oosterlinck, Richard Sylvester, et al.. (2012). Guía clínica del carcinoma urotelial de vejiga no músculo-invasivo de la Asociación Europea de Urología. Actualización de 2011. Actas Urológicas Españolas. 36(7). 389–402. 45 indexed citations
8.
Rouprêt, Morgan, Richard Zigeuner, Juan Palou, et al.. (2012). Guía clínica para el diagnóstico y tratamiento de los carcinomas de las células uroteliales de las vías urinarias superiores: actualización de 2011. Actas Urológicas Españolas. 36(1). 2–14. 18 indexed citations
9.
Babjuk, M., et al.. (2011). Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS). 60 indexed citations
10.
11.
12.
Soukup, Viktor, et al.. (2007). [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].. PubMed. 146(1). 63–7. 2 indexed citations
13.
Babjuk, M., Viktor Soukup, J. Mareš, et al.. (2006). Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder. Urology. 67(4). 756–761. 13 indexed citations
14.
Babjuk, M., et al.. (2004). Vliv fluorescenční cystoskopie na četnost recidív povrchových nádorů močového měchýře. 8(3). 14–16.
15.
Babjuk, M., et al.. (2003). Fluorescenční cystoskopie s intravezikální instilací kyseliny 5-aminolevulové a její využití k diagnostice nádorů močového měchýře - výsledky 125 vyšetření. 7(1). 11–14. 1 indexed citations
16.
Babjuk, M., Viktor Soukup, J. Mareš, et al.. (2002). The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome. International Urology and Nephrology. 34(4). 495–501. 17 indexed citations
17.
Babjuk, M., et al.. (2001). Léčba generalizovaného karcinomu ledviny. 5(3). 40–43.
18.
Babjuk, M., J Dušková, J Dvořáček, et al.. (2000). Prognostický význam imunohistochemického stanovení p53 ve tkáni povrchových nádorů močového měchýře. 4(2). 20–26.
19.
Babjuk, M., et al.. (2000). Hodnocení fotodynamického účinku syntetického porfyrinu TPPS4 [mesotetra (4-sulfonatophenyl) porphine] na buňky lidského nádoru močového měchýře in vitro. 4(4). 11–18. 1 indexed citations
20.
Novák, Jaroslav, Tomáš Hanuš, M. Babjuk, et al.. (1998). [Treatment of localized carcinoma of the prostate].. PubMed. 137(17). 528–31. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh Mostafid Breakdown of academic impact, for papers by Chih‐Hsiung Kang Breakdown of academic impact, for papers by Naotaka Nishiyama Breakdown of academic impact, for papers by William Martin‐Doyle Breakdown of academic impact, for papers by Catalona Wj Breakdown of academic impact, for papers by S. Holmäng Breakdown of academic impact, for papers by G. Zampa Breakdown of academic impact, for papers by Roberto Contieri Breakdown of academic impact, for papers by Gary Bokinsky Breakdown of academic impact, for papers by Soloway Ms
Rankless by CCL
2026